+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Coagulation Factor Concentrates Market - Global Forecast 2025-2030- Product Image
Coagulation Factor Concentrates Market - Global Forecast 2025-2030- Product Image
Sale

Coagulation Factor Concentrates Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887478
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The coagulation factor concentrates market is evolving rapidly, shaped by advances in therapy, changing patient expectations, and operational demands. Senior healthcare stakeholders recognize the importance of robust strategies to support product development and ensure sustainable growth. As competitive pressures intensify, data-driven insights and regionally tailored approaches are key for market leadership.

Coagulation Factor Concentrates Market Snapshot

The global market for coagulation factor concentrates is demonstrating steady growth, expanding from USD 8.84 billion in 2024 to USD 9.59 billion in 2025. This trajectory is expected to continue with a compound annual growth rate (CAGR) of 8.41%, reaching USD 14.35 billion by 2030. Market players are capitalizing on demand for new therapies, while supply chain strategies continue to adapt to global uncertainties and regulatory changes.

Scope & Segmentation: In-Depth Market Structure

This report analyzes the coagulation factor concentrates market through multiple comprehensive segments, integrating both product innovation and regional diversity:

  • Product Types: Plasma-derived and recombinant options, including extended half-life and standard half-life formulations
  • Indications: Hemophilia A (mild, moderate, severe), Hemophilia B (mild, moderate, severe), and Von Willebrand Disease subtypes (Type I, II, III)
  • Formulations: Liquid and lyophilized powder forms to address different clinical needs
  • End Users: Hospitals and specialty treatment centers as primary points of care
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies
  • Route of Administration: Intravenous delivery ensuring rapid onset of action
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (major markets such as United Kingdom, Germany, France, and regional economies), and Asia-Pacific (with focus on China, India, Japan, South Korea, and others)
  • Leading Companies: CSL Limited, Grifols S.A., Octapharma AG, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novo Nordisk A/S, Sanofi S.A., Bayer Aktiengesellschaft, LFB S.A., Kedrion S.p.A.

Key Takeaways for Senior Decision-Makers

  • Therapeutic innovation is driven by demand for reduced infusion frequency and personalized patient care, with extended half-life products leading differentiation.
  • Digital health platforms and wearable data integration are transforming real-world treatment management, supporting optimized dosing and proactive interventions.
  • Specialized contract manufacturing and strategic sourcing initiatives are crucial for risk mitigation, especially as global trade and supply chain challenges remain dynamic.
  • Regional adoption patterns are influenced by healthcare infrastructure strength, reimbursement systems, and local awareness initiatives, necessitating tailored go-to-market plans.
  • Strategic alliances—including collaborations with payers, research institutions, and advocacy groups—are supporting pipeline development and improving patient outcomes.

Tariff Impact on Coagulation Factor Concentrates

New tariff proposals in the United States present operational and cost challenges for manufacturers and distributors. Businesses are responding with strategies such as localized production, diversified sourcing, and enhanced regulatory compliance functions to ensure continuous access and protect margins. Adjustments in customs documentation and classification processes will be a priority for maintaining streamlined market entry.

Methodology & Data Sources

Analysis is built on primary interviews with healthcare experts, supply chain executives, and market access professionals. Secondary research includes peer-reviewed literature, global regulatory guidelines, and verified commercial data. All insights are validated through a structured process, including expert panel reviews and comprehensive data triangulation.

Why This Report Matters

  • Enables leaders to anticipate industry disruptions and align product portfolios with evolving clinical and operational benchmarks.
  • Provides actionable recommendations to optimize supply networks, enhance reimbursement strategies, and improve patient engagement.

Conclusion

The coagulation factor concentrates market is poised for substantial change, shaped by innovation, regulatory adaptation, and region-specific opportunities. Proactive investment in new therapies, resilient supply chains, and stakeholder collaboration will define future success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of extended half-life factor VIII and IX products to reduce infusion frequency and improve patient adherence
5.2. Increased investment in gene therapy trials targeting hemophilia A and B to offer one-time curative treatment opportunities
5.3. Emergence of biosimilar factor VIII and IX concentrates challenging established branded products on pricing and market access
5.4. Integration of pharmacokinetic-guided personalized dosing platforms to optimize coagulation factor concentrate prophylaxis regimens
5.5. Development of subcutaneous and nonintravenous factor concentrate formulations aimed at improving patient convenience and quality of life
5.6. Expansion of plasma collection networks and digital supply chain solutions to mitigate global shortages of source material
5.7. Application of real-world evidence and registry data to demonstrate long-term safety and efficacy of novel coagulation therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Coagulation Factor Concentrates Market, by Product Type
8.1. Introduction
8.2. Plasma Derived
8.3. Recombinant
8.3.1. Extended Half Life
8.3.2. Standard Half Life
9. Coagulation Factor Concentrates Market, by Indication
9.1. Introduction
9.2. Hemophilia A
9.2.1. Mild
9.2.2. Moderate
9.2.3. Severe
9.3. Hemophilia B
9.3.1. Mild
9.3.2. Moderate
9.3.3. Severe
9.4. Von Willebrand Disease
9.4.1. Type I
9.4.2. Type II
9.4.3. Type III
10. Coagulation Factor Concentrates Market, by Formulation
10.1. Introduction
10.2. Liquid
10.3. Lyophilized Powder
11. Coagulation Factor Concentrates Market, by End User
11.1. Introduction
11.2. Hospitals
11.3. Specialty Centers
12. Coagulation Factor Concentrates Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Coagulation Factor Concentrates Market, by Route Of Administration
13.1. Introduction
13.2. Intravenous
14. Americas Coagulation Factor Concentrates Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Coagulation Factor Concentrates Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Coagulation Factor Concentrates Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. CSL Limited
17.3.2. Grifols, S.A.
17.3.3. Octapharma AG
17.3.4. Takeda Pharmaceutical Company Limited
17.3.5. Pfizer Inc.
17.3.6. Novo Nordisk A/S
17.3.7. Sanofi S.A.
17.3.8. Bayer Aktiengesellschaft
17.3.9. LFB S.A.
17.3.10. Kedrion S.p.A.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. COAGULATION FACTOR CONCENTRATES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. COAGULATION FACTOR CONCENTRATES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. COAGULATION FACTOR CONCENTRATES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. COAGULATION FACTOR CONCENTRATES MARKET: RESEARCHAI
FIGURE 28. COAGULATION FACTOR CONCENTRATES MARKET: RESEARCHSTATISTICS
FIGURE 29. COAGULATION FACTOR CONCENTRATES MARKET: RESEARCHCONTACTS
FIGURE 30. COAGULATION FACTOR CONCENTRATES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COAGULATION FACTOR CONCENTRATES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY EXTENDED HALF LIFE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY EXTENDED HALF LIFE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STANDARD HALF LIFE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STANDARD HALF LIFE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY MILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY MILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY MODERATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY MODERATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY SEVERE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY SEVERE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY MILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY MILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY MODERATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY MODERATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY SEVERE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY SEVERE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 121. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 124. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 125. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 127. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2018-2024 (USD MILLION)
TABLE 128. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2025-2030 (USD MILLION)
TABLE 129. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2018-2024 (USD MILLION)
TABLE 130. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2025-2030 (USD MILLION)
TABLE 131. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2024 (USD MILLION)
TABLE 132. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2025-2030 (USD MILLION)
TABLE 133. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 144. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 145. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2018-2024 (USD MILLION)
TABLE 148. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2025-2030 (USD MILLION)
TABLE 149. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2018-2024 (USD MILLION)
TABLE 150. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2025-2030 (USD MILLION)
TABLE 151. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 246. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 247. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2018-2024 (USD MILLION)
TABLE 250. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2025-2030 (USD MILLION)
TABLE 251. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2018-2024 (USD MILLION)
TABLE 252. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2025-2030 (USD MILLION)
TABLE 253. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 266. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 267. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2018-2024 (USD MILLION)
TABLE 270. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2025-2030 (USD MILLION)
TABLE 271. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2018-2024 (USD MILLION)
TABLE 272. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2025-2030 (USD MILLION)
TABLE 273. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2024 (USD MILLION)
TABLE 274. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2025-2030 (USD MILLION)
TABLE 275. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 276. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 277. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA A, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA B, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY VON WILLEBRAND DISEASE, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA COAGULATION FACTOR CON

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Coagulation Factor Concentrates market report include:
  • CSL Limited
  • Grifols, S.A.
  • Octapharma AG
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Novo Nordisk A/S
  • Sanofi S.A.
  • Bayer Aktiengesellschaft
  • LFB S.A.
  • Kedrion S.p.A.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.59 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.35 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Recombinant Coagulation Factor Concentrate Market - Global Forecast 2025-2030 - Product Image

Recombinant Coagulation Factor Concentrate Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Coagulation Factor Deficiency Global Market Report 2025 - Product Image

Coagulation Factor Deficiency Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Coagulation Factor Concentrates - Global Strategic Business Report - Product Image

Coagulation Factor Concentrates - Global Strategic Business Report

  • Report
  • 129 Pages
  • Global
From
Coagulation Factor Deficiency Market - A Global and Regional Analysis: Focus on Deficiency Type, Product Type, End-User, and Region - Analysis and Forecast, 2025-2035 - Product Image

Coagulation Factor Deficiency Market - A Global and Regional Analysis: Focus on Deficiency Type, Product Type, End-User, and Region - Analysis and Forecast, 2025-2035

  • Report
  • 110 Pages
  • Global
From
Recombinant Coagulation Factors - Global Strategic Business Report - Product Image

Recombinant Coagulation Factors - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From

About the Coagulation Factor Market

The Coagulation Factor market is a segment of the Hematological Drugs market, which includes drugs used to treat blood-related disorders. Coagulation Factors are proteins that help the body form blood clots, and are used to treat conditions such as hemophilia, von Willebrand disease, and other bleeding disorders. These drugs are typically administered intravenously, and are often used in combination with other treatments. The Coagulation Factor market is highly competitive, with a number of companies offering products for the treatment of bleeding disorders. Some of the major players in the market include Pfizer, Novo Nordisk, Bayer, CSL Behring, and Shire. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.